Opinion
Are Targeted Drugs the Future in Colorectal Cancer?
- Author:
- David Kerr, MA, MD
Publish date: October 8, 2024
Preliminary results from three trials suggest some benefits of cetuximab plus irinotecan in patients who’d already had epidermal growth factor...